Stocktoria
Denali Therapeutics Inc. DNLI
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2017-12-08
Denali Therapeutics Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 13,174,562 | $305.9M |
| MILLENNIUM MANAGEMENT LLC | 1,272,950 | $24.4M |
| CITADEL ADVISORS LLC | 351,017 | $6.7M |
| AQR CAPITAL MANAGEMENT LLC | 102,579 | $2.0M |
| Point72 Asset Management, L.P. | 45,200 | $867,840 |
Source: SEC EDGAR filings · CIK 0001714899 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.